Stifel Downgrades Surgery Partners (SGRY) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Surgery Partners (SGRY) PT Lowered to $17 at Citi
August 11, 2017 8:42 AM EDTCiti lowered its price target on Surgery Partners (NASDAQ: SGRY) to $17.00 (from $28.00) while maintaining a Buy rating.
... MoreRaymond James Downgrades Surgery Partners (SGRY) to Market Perform
August 9, 2017 3:52 AM EDTRaymond James downgraded Surgery Partners (NASDAQ: SGRY) from Strong Buy to Market Perform.
For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.
Shares of Surgery Partners closed at $19.15 yesterday.
... MoreKeyBanc Downgrades Surgery Partners (SGRY) to Sector Weight
August 9, 2017 3:45 AM EDTKeyBanc downgraded Surgery Partners (NASDAQ: SGRY) from Overweight to Sector Weight.
For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.
Shares of Surgery Partners closed at $19.15 yesterday.
... MoreSurgery Partners, Inc. (SGRY) Misses Q2 EPS by 27c, Miss on Revenues; Offers FY17 Revenues
August 8, 2017 4:15 PM EDTSurgery Partners, Inc. (NASDAQ: SGRY) reported Q2 EPS of ($0.09), $0.27 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $288.4 million versus the consensus estimate of $314.22 million.
Full Year 2017 Guidance
For 2017, the Company is modifying the guidance provided on our conference call in March... More
